TABLE B-1 Adverse Events Included in the Vaccine Chapters
| Adverse Event | MMR Vaccine Chapter 4 | Varicella Vaccine Chapter 5 | Influenza Vaccine Chapter 6 | Hepatitis A Vaccine Chapter 7 | Hepatitis B Vaccine Chapter 8 | HPV Vaccine Chapter 9 | DT–, TT–, and aP–Containing Vaccines Chapter 10 | Meningococcal Vaccine Chapter 11 | Injected-Related Events Chapter 12 |
| Disseminated Oka VZV without Other Organ Involvement |
● |
||||||||
| Disseminated Oka VZV with Subsequent Infection Resulting in Pneumonia, Meningitis, or Hepatitis |
● |
||||||||
| Vaccine Strain Viral Reactivation without Other Organ Involvement |
● |
||||||||
| Vaccine Strain Viral Reactivation with Subsequent Infection Resulting in Meningitis or Encephalitis |
● |
||||||||
| Measles Inclusion Body Encephalitis |
● |
||||||||
| Encephalitis |
● |
● |
● |
● |
● |
||||
| Encephalopathy |
● |
● |
● |
● |
● |
● |
|||
| Infantile Spasms |
● |
||||||||
| Seizures |
● |
● |
❍ |
● |
● |
||||
| Meningitis |
❍ |
● |
|||||||
| Cerebellar Ataxia |
● |
||||||||
| Ataxia |
● |
● |
|||||||
| Autism |
● |
● |
|||||||
| Acute Disseminated Encephalomyelitis |
● |
● |
● |
● |
● |
● |
● |
||
| Transverse Myelitis |
● |
● |
● |
● |
● |
● |
● |
||
| Optic Neuritis |
❍ |
❍ |
❍ |
❍ |
|||||
| Neuromyelitis Optica |
❍ |
● |
● |
||||||
| Multiple Sclerosis |
● |
● |
● |
● |
● |
● |
|||
| First Demyelinating Event |
● |
||||||||
| Guillain-Barré Syndrome |
● |
● |
● |
● |
● |
● |
● |
||
| Chronic Inflammatory Disseminated Polyneuropathy |
● |
● |
● |
● |
● |
● |
|||
| Opsoclonus Myoclonus Syndrome |
● |
● |
|||||||
| Bell’s Palsy |
● |
● |
● |
||||||
| Brachial Neuritis |
● |
● |
● |
● |
|||||
| Amyotrophic Lateral Sclerosis |
● |
||||||||
| Small Fiber Neuropathy |
❍ |
● |
| Adverse Event | MMR Vaccine Chapter 4 | Varicella Vaccine Chapter 5 | Influenza Vaccine Chapter 6 | Hepatitis A Vaccine Chapter 7 | Hepatitis B Vaccine Chapter 8 | HPV Vaccine Chapter 9 | DT–, TT–, and aP–Containing Vaccines Chapter 10 | Meningococcal Vaccine Chapter 11 | Injected-Related Events Chapter 12 |
| Anaphylaxis |
● |
● |
● |
● |
● |
● |
● |
● |
|
| Chronic Urticaria |
● |
||||||||
| Serum Sickness |
● |
||||||||
| Asthma |
● |
||||||||
| Erythema Nodosum |
❍ |
||||||||
| Systemic Lupus Erythematous |
● |
||||||||
| Vasculitis |
● |
||||||||
| Polyarteritis Nodosa |
● |
||||||||
| Psoriatic Arthritis | |||||||||
| Reactive Arthritis |
● |
||||||||
| Rheumatoid Arthritis |
● |
||||||||
| Juvenile Idiopathic Arthritis |
● |
||||||||
| Arthropathy (Arthralgia and Arthritis) |
● |
● |
● |
● |
● |
||||
| Type 1 Diabetes |
● |
● |
● |
||||||
| Hepatitis (Autoimmune) |
● |
||||||||
| Myocarditis |
● |
||||||||
| Pancreatitis |
● |
||||||||
| Hepatitis |
● |
||||||||
| Thromboembolic Events |
● |
||||||||
| Stroke |
❍ |
● |
|||||||
| Hypercoagulable States |
● |
||||||||
| Myocardial Infarction |
● |
||||||||
| Chronic Fatigue Syndrome |
● |
||||||||
| Chronic Headaches |
● |
||||||||
| Fibromyalgia |
● |
● |
● |
● |
|||||
| Sudden Infant Death Syndrome |
● |
||||||||
| Hearing Loss |
● |
||||||||
| All-Cause Mortality |
❍ |
||||||||
| Oculorespiratory Syndrome |
● |
||||||||
| Thrombocytopenia |
● |
||||||||
| Immune Thrombocytopenic Purpura |
● |
||||||||
| Complex Regional Pain Syndrome |
● |
||||||||
| Deltoid Bursitis |
● |
||||||||
| Syncope |
● |
||||||||
NOTE: Adverse events indicated by “❍” were added to the list by the committee.